(Q28251201)

https://api.crossref.org/works/10.1196/ANNALS.1346.030

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 April 2017

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1346.030

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 April 2017

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1346.030

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

21 April 2017

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1346.030

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 April 2017

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1346.030

IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1346.030

Exposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation

21 April 2017

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1346.030

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

21 April 2017

1 reference

https://api.crossref.org/works/10.1196/ANNALS.1346.030

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

21 April 2017

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Postmenopausal osteoporosis, T cells, and immune dysfunction

21 April 2017

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Minireview: the OPG/RANKL/RANK system

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Cytokines, estrogen, and postmenopausal osteoporosis--the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Interleukin 7 and estrogen-induced bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Interleukin-7: master regulator of peripheral T-cell homeostasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Long-term treatment of osteopetrosis with recombinant human interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

TGF-beta receptors and actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

TGF-beta receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Osteoblast gene expression is differentially regulated by TGF-beta isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Regulation of osteoclastogenesis and RANK expression by TGF-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Mechanisms by which high-dose estrogen therapy produces anabolic skeletal effects in postmenopausal women: role of locally produced growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Changes in proinflammatory cytokine activity after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Use of bisphosphonates in hypercalcaemia due to malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Effects of interleukin-1 beta and tumor necrosis factor-alpha on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Peripheral selection of T cell repertoires: the role of continuous thymus output

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Cellular tolerance as a dynamic state of the adaptable lymphocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Self-tolerance: context dependent tuning of T cell antigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Differential requirements for survival and proliferation of CD8 naïve or memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Transcriptional regulation of the MHC class II antigen presentation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Transforming growth factor-beta in T-cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Estrogen prevents bone loss through transforming growth factor beta signaling in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1346.030